Loading asset research
Dermata Therapeutics Inc. Common Stock
DRMANasdaq · USD · StocksQuote as of · Exchange session not verified$1.19
-0.83%
Today
DRMA
Loading 1D prices…
Market cap
$5.9M
Volume
24.9K
52w high
$6.2252w low
$0.951Company profile
Dermata Therapeutics Inc. Common Stock
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
9
Fiscal year end
1231
CIK
1853816
Session & valuation
Open$1.23
Previous close$1.20
Day high$1.23
Day low$1.16
30-day avg. volume1.5M
Outstanding shares4M
Diluted EPS-$8.16
Latest annual period
P/E (trailing)-0.15
P/E (forward)-0.31
Price / book1.37
Beta0.69
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KAPAKairos Pharma Ltd. Common Stock | $6M | $0.00 | — | -$0.30 | +4.64% | Buy |
| PCSAProcessa Pharmaceuticals Inc. Common Stock | $5.8M | $0.00 | — | -$10.36 | +12.43% | Buy |
| ACXPAcurx Pharmaceuticals Inc. Common Stock | $6M | $0.00 | — | -$5.32 | 0.00% | Buy |
| XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares | $6.3M | $0.00 | — | -$0.80 | +1.59% | Unrated |
| NCNANuCana plc American Depositary Share | $5.5M | — | — | $0.00 | -1.49% | Unrated |